(-0.88%) 4 967.23 points
(0.56%) 37 986 points
(-2.05%) 15 282 points
(0.62%) $83.24
(0.17%) $1.760
(0.36%) $2 406.70
(1.29%) $28.75
(-1.17%) $943.30
(-0.14%) $0.938
(-0.28%) $11.01
(0.55%) $0.808
(-0.96%) $93.00
Live Chart Being Loaded With Signals
Austar Lifesciences Limited, an investment holding company, provides integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally...
Stats | |
---|---|
Today's Volume | 246 000 |
Average Volume | 513 511 |
Market Cap | 512.58M |
EPS | HKD0 ( 2023-08-29 ) |
Last Dividend | HKD0.0500 ( 2015-05-19 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | -16.67 |
ATR14 | HKD0.0230 (2.30%) |
Austar Lifesciences Ltd Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Austar Lifesciences Ltd Financials
Annual | 2022 |
Revenue: | HKD2.23B |
Gross Profit: | HKD462.67M (20.76 %) |
EPS: | HKD0.170 |
Q2 | 2023 |
Revenue: | HKD964.27M |
Gross Profit: | HKD147.27M (15.27 %) |
EPS: | HKD-0.0800 |
Q4 | 2022 |
Revenue: | HKD1.12B |
Gross Profit: | HKD226.93M (20.18 %) |
EPS: | HKD0.0800 |
Q2 | 2022 |
Revenue: | HKD1.10B |
Gross Profit: | HKD235.74M (21.35 %) |
EPS: | HKD0.0894 |
Financial Reports:
No articles found.
Austar Lifesciences Ltd Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
First Dividend | HKD0.0500 | 2015-05-19 |
Last Dividend | HKD0.0500 | 2015-05-19 |
Next Dividend | HKD0 | N/A |
Payout Date | 2015-06-26 | |
Next Payout Date | N/A | |
# dividends | 1 | -- |
Total Paid Out | HKD0.0500 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 0.97 | -- |
Div. Sustainability Score | 5.03 | |
Div.Growth Potential Score | 1.377 | |
Div. Directional Score | 3.20 | -- |
Year | Amount | Yield |
---|
With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
3888.HK | Ex Dividend Knight | 2023-06-02 | Annually | 0 | 0.00% | |
1760.HK | Ex Dividend Junior | 2023-06-01 | Annually | 0 | 0.00% | |
0806.HK | Ex Dividend Junior | 2023-05-03 | Annually | 0 | 0.00% | |
2342.HK | Ex Dividend Knight | 2023-09-07 | Annually | 0 | 0.00% | |
1314.HK | Ex Dividend Junior | 2023-06-30 | Annually | 0 | 0.00% | |
0375.HK | Ex Dividend Knight | 2023-09-27 | Annually | 0 | 0.00% | |
6127.HK | Ex Dividend Junior | 2023-06-20 | Annually | 0 | 0.00% | |
1876.HK | Ex Dividend Knight | 2023-05-15 | Annually | 0 | 0.00% | |
0900.HK | Ex Dividend Knight | 2023-07-04 | Semi-Annually | 0 | 0.00% | |
0038.HK | Ex Dividend Junior | 2023-06-08 | Sporadic | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.000801 | 1.500 | 9.98 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.000727 | 1.200 | 9.98 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.00191 | 1.500 | -1.090 | -1.635 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.284 | 0.800 | 8.58 | 6.87 | [1 - 3] |
quickRatioTTM | 0.861 | 0.800 | 9.64 | 7.71 | [0.8 - 2.5] |
cashRatioTTM | 0.0942 | 1.500 | -0.588 | -0.881 | [0.2 - 2] |
debtRatioTTM | 0.162 | -1.500 | 7.30 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.121 | 2.00 | -0.0402 | -0.0804 | [0 - 30] |
freeCashFlowPerShareTTM | -0.257 | 2.00 | -0.129 | -0.257 | [0 - 20] |
debtEquityRatioTTM | 0.434 | -1.500 | 8.27 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.179 | 1.000 | -0.348 | -0.348 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.0102 | 1.000 | -2.20 | -2.20 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -0.162 | 1.000 | -2.01 | -2.01 | [0.2 - 2] |
assetTurnoverTTM | 0.907 | 0.800 | 7.28 | 5.83 | [0.5 - 2] |
Total Score | 5.03 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 308.05 | 1.000 | 10.00 | 0 | [1 - 100] |
returnOnEquityTTM | 0.00191 | 2.50 | -0.701 | -1.635 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.257 | 2.00 | -0.0857 | -0.257 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.121 | 2.00 | -0.0402 | -0.0804 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 1.101 | 1.500 | 5.99 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -0.0288 | 1.000 | -3.22 | 0 | [0.1 - 0.5] |
Total Score | 1.377 |
Austar Lifesciences Ltd
Austar Lifesciences Limited, an investment holding company, provides integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally. It operates through six segments: Liquid and Bioprocess System; Clean Room and Automation Control and Monitoring System; Powder and Solid System; GMP Compliance Service; Life Science Consumables; and Distribution and Agency of Pharmaceutical Equipment. The company offers liquid and bioprocess systems, including pharmaceutical water, and liquid preparation and bioprocess systems; powder and solid systems; clean utility equipment and systems; clean room, automation control, and monitor systems; and freeze-dryer, sterile filling, and visual inspection equipment. It also provides pharmaceutical process contamination control products; packaging and aseptic containment products; biosafety and lab animal equipment and consumables; laboratory one-stop solutions; and single-use bioprocess equipment and consumables. In addition, the company offers design, quality risk control, consulting, research and development support, process engineering, digitalization construction, after-sale, on-site, upgrading, relocation, and asset management services. Further, it is involved in the agency and distribution of pharmaceutical equipment, as well as provides assembly and pre-assembly services. The company was founded in 1991 and is headquartered in Shanghai, China.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators